Cargando…
The Value of Serum Immunoglobulin Free Light Chain Assessment in Patients with Monoclonal Gammopathies and Acute Renal Failure
Objective: Immunoglobulin free light chain (FLC) abnormalities are common in patients with monoclonal gammopathies and the kidneys are the most affected organs. Immunoassays that provide quantitative measurement of FLC in serum indicate monoclonal FLC production based on the presence of an abnormal...
Autores principales: | Cirit, Mustafa, Üzüm, Atilla, Özen, Pınar, Şentürk, Banu A., Bozkaya, Giray, Payzin, Bahriye, Ural, Orçun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781632/ https://www.ncbi.nlm.nih.gov/pubmed/24385726 http://dx.doi.org/10.5505/tjh.2012.48640 |
Ejemplares similares
-
Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
por: Girard, Louis-Pierre, et al.
Publicado: (2022) -
Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies
por: Lee, Won Sok, et al.
Publicado: (2018) -
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
por: Tietsche de Moraes Hungria, Vania, et al.
Publicado: (2016) -
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies
por: Kumar, Shaji, et al.
Publicado: (2019) -
Crystal‐storing histiocytosis associated with monoclonal kappa light chain gammopathy
por: Lesesve, Jean‐François, et al.
Publicado: (2022)